Tezspire’s Success in Eosinophilic Esophagitis Trial Paves Way for Third Indication and Blockbuster Market Expansion
admin AstraZeneca and Amgen have announced a significant clinical triumph for their co-developed biologic, Tezspire (tezepelumab),...
pharma
Outer Bio Emerges from Stealth with Month-Long Living Skin Tissue and AI Platform, Revolutionizing Skincare and Therapeutic Discovery
Outer Bio, a pioneering startup operating at the nexus of biotechnology and artificial intelligence, has...
Zepbound Poised to Lower Healthcare Costs, McKesson Expands, J&J Scores Key Approval Amidst Dynamic Biopharma Landscape
The biopharmaceutical sector is witnessing a flurry of significant developments, from pioneering real-world data demonstrating...
Biohaven Divests Flagship Epilepsy Drug Opakalim to SK Biopharmaceuticals Amidst Financial Strain and Pipeline Restructuring
Biohaven Pharmaceuticals, a company in its second iteration following a high-profile acquisition and subsequent spin-off,...
Spyre tumbles as immune drug misses mark in rheumatoid arthritis
The biopharmaceutical landscape witnessed a significant tremor on Wednesday, August 26, 2026, as Spyre Therapeutics,...
Rasonque Secures Rapid FDA Approval, Heralding a New Era for Pancreatic Cancer Treatment and Positioning Revolution Medicines for Blockbuster Success.
The biopharmaceutical landscape was fundamentally reshaped on August 26, 2026, with the unprecedentedly swift approval...
Cellares Initiates Major Restructuring and Layoffs Following Termination of Key Pharmaceutical Contract
Cellares, a prominent biotechnology startup specializing in automated cell therapy manufacturing, is undergoing a significant...
New Jazz cancer drug approval could drive blockbuster sales
The U.S. Food and Drug Administration (FDA) has granted an expanded approval for Ziihera (zanidatamab)...
Roche, Eli Lilly get FDA nod for new Alzheimer’s blood test
The landscape of Alzheimer’s disease diagnostics is poised for a significant transformation with the announcement...
Venture Capital Funding for Women’s Health Plummets Amid Broader Market Reset, Sparks Strategic Re-evaluation
After experiencing a surge to record levels in 2024, venture capital investments in women’s health...
